These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3901325)

  • 21. [Use of estulic in patients with arterial hypertension].
    Kukes VG; Spasskiĭ AV; Alkhazov AI; Rudakov AG; Zisel'man SB
    Sov Med; 1985; (12):57-61. PubMed ID: 3913006
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N; Knaup G
    Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemodynamics in hypertensive patients before and during guanfacine treatment.
    Schäfer N; Rauh J; Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
    Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
    Bazika V
    Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanfacine (Estulic) in the treatment of hypertension.
    Cor Vasa; 1987; 29(4 Suppl 1):1-52. PubMed ID: 3315446
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of guanfacine on ambulatory blood pressure and its variability in elderly patients with essential hypertension.
    Dupont AG; Vanderniepen P; Six RO
    Br J Clin Pharmacol; 1987 Apr; 23(4):397-401. PubMed ID: 3555578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M; Weiss Y; Georges D
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanfacine: effects of long-term treatment and withdrawal.
    Reid JL; Zamboulis C; Hamilton CA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term clinical experience with guanfacine.
    Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
    Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antihypertensive effect of guanfacine compared with methyldopa.
    van der Merwe CJ; Kruger SA
    S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The place of guanfacine in the treatment of essential arterial hypertension].
    Koaté P; Diouf S; Sylla M; Sarr M; Ba SA
    Dakar Med; 1983; 28(2):321-36. PubMed ID: 6360603
    [No Abstract]   [Full Text] [Related]  

  • 35. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
    Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
    Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of guanfacine in the treatment of arterial hypertension].
    de Broucker D; Graux P; Dutoit A; Croccel L
    LARC Med; 1982; 2(7):613-5. PubMed ID: 6762476
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study of the antihypertensive effect of guanfacine and guanethidine].
    Kállay K; Szám I; Káldi N
    Orv Hetil; 1981 Jul; 122(29):1777-83. PubMed ID: 7027137
    [No Abstract]   [Full Text] [Related]  

  • 39. [A clinical study of guanfacine in the treatment of arterial hypertension].
    Kheder A; Souilem J; Hassine L; Ben Maiz H; Ben Moussa F; Ben Ayed H
    Tunis Med; 1987 Nov; 65(11):709-12. PubMed ID: 3332951
    [No Abstract]   [Full Text] [Related]  

  • 40. [Extracardiac systemic pharmacodynamic effects of estulic (guanfacine)].
    Kukes VG; Spasskiĭ AV; Tsoĭ AN; Blinkov IL; Karpenko EV
    Klin Med (Mosk); 1987 Jan; 65(1):46-9. PubMed ID: 3550283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.